Skip to main content
. 2020 Jun 12;12(6):1551. doi: 10.3390/cancers12061551

Table 4.

Comparing mortality rates between aspirin users (≥180 days) and non-users in patients (n = 333) with a subdivision of Stages III and IV NPC in the T category.

Stages III and IV a n = 333 Low-Dose Aspirin p-Value
Non-Users b n = 268 Users ≥ 180 Days n = 65 Aspirin
Non-Users vs.
User
T1 and 2 vs. T3 and 4
T1 and 2 <0.001 ***
Alive 53 (62.4%) 23 (88.5%) 0.014 *
Dead due to NPC 25 (29.4%) 3 (11.5%)
Other Causes of Dead 7 (8.2%) 0 (0.0%)
T3 and 4
Alive 86 (47.0%) 32 (82.1%) <0.001 ***
Dead due to NPC 71 (38.8%) 4 (10.3%)
Other Causes of Dead 26 (14.2%) 3 (7.7%)

Abbreviation: vs. versus; a Stages IVa and IVb only; b One patient with missing data on T category of cancer; * p ≤ 0.05; *** p ≤ 0.001.